Vijaya Diagnostic Centre Limited (BOM:543350)
India · Delayed Price · Currency is INR | Market Cap | 134.64B +32.1% |
| Revenue (ttm) | 8.14B +19.5% |
| Net Income | 1.73B +20.9% |
| EPS | 16.79 +20.6% |
| Shares Out | n/a |
| PE Ratio | 77.84 |
| Forward PE | 62.78 |
| Dividend | 2.00 (0.15%) |
| Ex-Dividend Date | Aug 29, 2025 |
| Volume | 14,692 |
| Open | 1,279.95 |
| Previous Close | 1,261.15 |
| Day's Range | 1,270.00 - 1,323.15 |
| 52-Week Range | 847.90 - 1,376.25 |
| Beta | n/a |
| Analysts | Buy |
| Price Target | 1,362.20 (+4.1%) |
| Earnings Date | May 7, 2026 |
About Vijaya Diagnostic Centre
Vijaya Diagnostic Centre Limited provides diagnostic services for patients in India. The company offers laboratory services, including clinical pathology, microbiology, haematology, serology, histopathology, cytogenetics, biochemistry, molecular diagnostics, CT scan, magnetic resonance imaging (MRI) scan, ultrasound, X-ray, cardiology, gastroenterology, nuclear medicine and PET/CT, and MRI-3T services. It also provides health checkups and home sample collection services. Vijaya Diagnostic Centre Limited was founded in 1981 and is based in Hyder... [Read more]
Financial Performance
In fiscal year 2026, Vijaya Diagnostic Centre's revenue was 8.14 billion, an increase of 19.49% compared to the previous year's 6.81 billion. Earnings were 1.73 billion, an increase of 20.90%.
Financial StatementsNews
Vijaya Diagnostic Centre Transcript: Q4 25/26
Q4 FY 2026 saw 26.6% YoY revenue growth and 43.5% EBITDA margin, driven by strong volume and network expansion. FY 2026 revenue crossed INR 800 crore, with robust growth in Hyderabad, Pune, and Kolkata, and continued investment in technology and talent.
Vijaya Diagnostic Centre Quarterly report: Q4 2026
Vijaya Diagnostic Centre has published its Q4 2026 quarterly earnings report on May 8, 2026.
Vijaya Diagnostic Centre Slides: Q4 2026
Vijaya Diagnostic Centre has posted slides in relation to its Q4 2026 quarterly earnings report, which was published on May 8, 2026.
Vijaya Diagnostic Centre Transcript: Q3 25/26
Q3 FY26 saw record revenue of INR 205 crore, up 21.4% year-over-year, with strong growth in both radiology and pathology. EBITDA margin improved to 41.9%, and the wellness segment reached 15% of revenue. Expansion continues with a focus on stabilizing new hubs and investing in technology.
Vijaya Diagnostic Centre Quarterly report: Q3 2026
Vijaya Diagnostic Centre has published its Q3 2026 quarterly earnings report on February 13, 2026.
Vijaya Diagnostic Centre Slides: Q3 2026
Vijaya Diagnostic Centre has posted slides in relation to its Q3 2026 quarterly earnings report, which was published on February 13, 2026.
Vijaya Diagnostic Centre Transcript: Q2 25/26
Q2 FY26 saw 10.2% YoY revenue growth and strong margins, led by radiology and new hub launches. Guidance for 15% CAGR and 38-40% EBITDA margin is maintained, with expansion focused on Bengaluru, Kolkata, and tier-two cities.
Vijaya Diagnostic Centre Quarterly report: Q2 2026
Vijaya Diagnostic Centre has published its Q2 2026 quarterly earnings report on November 4, 2025.
Vijaya Diagnostic Centre Slides: Q2 2026
Vijaya Diagnostic Centre has posted slides in relation to its Q2 2026 quarterly earnings report, which was published on November 4, 2025.
Vijaya Diagnostic Centre Transcript: Q1 25/26
Q1 FY26 saw 20.4% revenue growth, strong margins, and robust volume gains, with new hubs ramping up well and Hyderabad returning to double-digit growth. Guidance for 15%+ revenue growth and 38%-39% EBITDA margin is maintained, with continued expansion and market share gains in new geographies.
Vijaya Diagnostic Centre Quarterly report: Q1 2026
Vijaya Diagnostic Centre has published its Q1 2026 quarterly earnings report on July 28, 2025.
Vijaya Diagnostic Centre Slides: Q1 2026
Vijaya Diagnostic Centre has posted slides in relation to its Q1 2026 quarterly earnings report, which was published on July 28, 2025.